Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications

Mattia Galli, Francesco Franchi, Fabiana Rollini, Luis Ortega-Paz, Domenico D’Amario, Raffaele De Caterina, Roxana Mehran, C. Michael Gibson, Dominick J. Angiolillo

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science